Literature DB >> 17016562

VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.

Lorenz Vogt1, Nicole Schmitz, Michael O Kurrer, Monika Bauer, Heather I Hinton, Silvia Behnke, Dominique Gatto, Peter Sebbel, Roger R Beerli, Ivo Sonderegger, Manfred Kopf, Philippe Saudan, Martin F Bachmann.   

Abstract

T cell activation by APCs is positively and negatively regulated by members of the B7 family. We have identified a previously unknown function for B7 family-related protein V-set and Ig domain-containing 4 (VSIG4). In vitro experiments using VSIG4-Ig fusion molecules showed that VSIG4 is a strong negative regulator of murine and human T cell proliferation and IL-2 production. Administration to mice of soluble VSIG4-Ig fusion molecules reduced the induction of T cell responses in vivo and inhibited the production of Th cell-dependent IgG responses. Unlike that of B7 family members, surface expression of VSIG4 was restricted to resting tissue macrophages and absent upon activation by LPS or in autoimmune inflammatory foci. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016562      PMCID: PMC1578631          DOI: 10.1172/JCI25673

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered.

Authors:  M F Bachmann; A Gallimore; E Jones; B Ecabert; H Acha-Orbea; M Kopf
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

Review 2.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

3.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.

Authors:  Elizabeth A Tivol; Jack Gorski
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

5.  Recent improvements to the SMART domain-based sequence annotation resource.

Authors:  Ivica Letunic; Leo Goodstadt; Nicholas J Dickens; Tobias Doerks; Joerg Schultz; Richard Mott; Francesca Ciccarelli; Richard R Copley; Chris P Ponting; Peer Bork
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

6.  Z39Ig is co-expressed with activated macrophage genes.

Authors:  Michael G Walker
Journal:  Biochim Biophys Acta       Date:  2002-04-12

7.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

8.  Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis.

Authors:  Jung Hoon Ahn; Yoon Lee; ChoonJu Jeon; Sang-Jin Lee; Byung-Hak Lee; Kang Duk Choi; Yong-Soo Bae
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

9.  Characterization of mouse and human B7-H3 genes.

Authors:  Mingyi Sun; Sabrina Richards; Durbaka V R Prasad; Xoi Muoi Mai; Alexander Rudensky; Chen Dong
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

View more
  86 in total

Review 1.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Solving the plot: early events are the key to diabetes intervention.

Authors:  Alexander V Chervonsky
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

3.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

Authors:  A Rajakumar; T Chu; D E Handley; K D Bunce; B Burke; C A Hubel; A Jeyabalan; D G Peters
Journal:  Placenta       Date:  2010-11-13       Impact factor: 3.481

4.  VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.

Authors:  Tao Xu; Ying Jiang; Yong Yan; Hongxiang Wang; Chengyin Lu; Hanchong Xu; Weiqing Li; Da Fu; Yicheng Lu; Juxiang Chen
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 5.  Inhibitory costimulation and anti-tumor immunity.

Authors:  Natalia Martin-Orozco; Chen Dong
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

6.  Regulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokines.

Authors:  Nick N Gorgani; Umaporn Thathaisong; Violet R S Mukaro; Ornnuthchar Poungpair; Amanda Tirimacco; Charles S T Hii; Antonio Ferrante
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 7.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

8.  CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites.

Authors:  Katharine M Irvine; Xuan Banh; Victoria L Gadd; Kyle K Wojcik; Juliana K Ariffin; Sara Jose; Samuel Lukowski; Gregory J Baillie; Matthew J Sweet; Elizabeth E Powell
Journal:  JCI Insight       Date:  2016-06-02

Review 9.  Harnessing the immune system to treat cancer.

Authors:  Nina Bhardwaj
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.